Cargando…
Screening for Liver Fibrosis in the General Population: Where Do We Stand in 2022?
Approximately 30% of the worldwide population has at least one risk factor for liver disease. Identifying advanced liver disease before the occurrence of complications remains a difficult challenge in clinical practice, where diagnosis comes too late for many patients, at the time of liver decompens...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818643/ https://www.ncbi.nlm.nih.gov/pubmed/36611384 http://dx.doi.org/10.3390/diagnostics13010091 |